PERNIX THERAPEUTICS HOLDINGS, INC. 4

4 · PERNIX THERAPEUTICS HOLDINGS, INC. · Filed Feb 29, 2016

Insider Transaction Report

Form 4
Period: 2016-02-25
Golembiewski Michael Joseph
VP Finance, Controller, CAO
Transactions
  • Award

    Option (right to buy)

    2016-02-25+65,00065,000 total
    Exercise: $2.14Exp: 2026-02-25Common Stock (65,000 underlying)
Footnotes (1)
  • [F1]The stock options vest in annual 16,250 share installments with the first installment vesting on the first anniversary date of grant and the final installment vesting on the fourth anniversary thereof.

Documents

1 file
  • 4
    issuerdirect_section16.xmlPrimary

    PRIMARY DOCUMENT